Transurethral RollerLoop vapor resection of prostate for treatment of symptomatic benign prostatic hyperplasia: A 2-year follow-up study

2006 ◽  
Vol 40 (5) ◽  
pp. 409-415 ◽  
Author(s):  
Chih-Kuang Liu ◽  
Wen-Kai Lee ◽  
Ming-Chung Ko ◽  
Huey-Sheng Jeng ◽  
Han-Sun Chiang ◽  
...  
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Prostatic Hyperplasia ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Follow Up Study

RACE, ETHNICITY AND BENIGN PROSTATIC HYPERPLASIA IN THE HEALTH PROFESSIONALS FOLLOW-UP STUDY

2000 ◽  
Vol 163 (2) ◽  
pp. 490-495 ◽  
Author(s):  
ELIZABETH A. PLATZ ◽  
ICHIRO KAWACHI ◽  
ERIC B. RIMM ◽  
WALTER C. WILLETT ◽  
EDWARD GIOVANNUCCI
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Health Professionals ◽  
Prostatic Hyperplasia ◽  
Follow Up Study ◽  
Race Ethnicity

scholarly journals A Comparative Study of Efficacy and Safety Between Tamsulosin and Terazosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia

2016 ◽  
Vol 15 (1) ◽  
pp. 17-21
Author(s):  
Sakhawat Mahmud Khan ◽  
Md Matiar Rahaman Khan ◽  
Shahin Akhter ◽  
Md Mizanur Rahman
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Prostatic Hyperplasia ◽  
Common Disease ◽  
Efficacy And Safety ◽  
College Hospital ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Group A ◽  
Group B ◽  
A Prospective Study

Background: Lower urinary tract symptoms suggestive of symptomatic Benign Prostatic Hyperplasia (BPH) are a very common disease in elderly men .The incidence of benign prostatic hyperplasia is age related.Objectives: To compare the efficacy and safety of Tamsulosin and Terazosin in the treatment of symptomatic Benign Prostatic Hyperplasia.Methods: This was a prospective study carried out in the Department of Urology, Chittagong Medial College Hospital, Chittagong, Bangladesh during the period of July to December 2014. Total 40 patients of 45-80 years of age were consequently selected according to inclusion criteria. After completion of baseline clinical evaluation and investigations, participants were divided into two groups, group A and group B. Group A (n=20) was given Terazosin 1mg daily for 3 days at bed time and then 2 mg daily at bed time for 2 months. Group B (n=20) was given Tamsulosin, 0.4 mg per day for 2 months. Efficacy was evaluated of each group after 2 month follow up and lastly a comparison was made between them. The parameters monitored were International Prostate Symptoms Score (IPSS) Maximum urine flow rate (Qmax) and Post Voidal Residual Volume (PVR). Tamsulosin 0.4 mg and Terazosin 2 mg once daily for 8 weeks both are effective in relieving symptoms of BPH but Tamsulosin is superior to Terazosin in improvement of total IPSS (p<0.001) and Qmax (p<0.01) PVR (p<0.01) at the end point.Results: Outcome of parameters at follow up after 2 months. Tamsulosin group showed significant improvement of IPSS (p<0.05) PVR (p<0.001) and Qmax (p<0.001) than Terazosin. The incidence of adverse events by administration of Tamsulosin was less than that by Terazosin.Conclusion: Tamsulosin appears to have more efficacy and safety than Terazosin in symptomatic BPH.Chatt  Shi Hosp Med Coll J; Vol.15 (1); Jan 2016; Page 17-21

Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the health professionals follow-up study

Urology ◽  
1998 ◽  
Vol 51 (3) ◽  
pp. 422-427 ◽  
Author(s):  
Garry Welch ◽  
Ichiro Kawachi ◽  
Michael J. Barry ◽  
Edward Giovannucci ◽  
Graham A. Colditz ◽  
...  
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Health Professionals ◽  
Prostatic Hyperplasia ◽  
Follow Up Study

scholarly journals TRANSURETHRAL MICROWAVE THERMOTHERAPY FOR BENIGN PROSTATIC HYPERPLASIA: A 1-YEAR FOLLOW-UP STUDY

1994 ◽  
Vol 85 (12) ◽  
pp. 1723-1728
Author(s):  
Yutaka Kurita ◽  
Shinjui Kageyama ◽  
Tomomi Ushiyama ◽  
Kazuo Suzuki ◽  
Kimio Fujita ◽  
...  
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Prostatic Hyperplasia ◽  
Follow Up Study ◽  
Transurethral Microwave Thermotherapy

RACE, ETHNICITY AND BENIGN PROSTATIC HYPERPLASIA IN THE HEALTH PROFESSIONALS FOLLOW-UP STUDY

2000 ◽  
pp. 490 ◽  
Author(s):  
ELIZABETH A. PLATZ ◽  
ICHIRO KAWACHI ◽  
ERIC B. RIMM ◽  
WALTER C. WILLETT ◽  
EDWARD GIOVANNUCCI
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Health Professionals ◽  
Prostatic Hyperplasia ◽  
Follow Up Study ◽  
Race Ethnicity

scholarly journals Photoselective vaporization of the prostate using GreenLight 120-W lithium triborate laser to treat symptomatic benign prostatic hyperplasia: A single-centre prospective study

2013 ◽  
Vol 7 (3-4) ◽  
pp. e193-6 ◽  
Author(s):  
Hisham A. Mosli ◽  
Taha A. Abdel-Meguid ◽  
Mohammad H. Abdulwahhab ◽  
Ahmad Al-Sayyad ◽  
Hasan M. Farsi ◽  
...  
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Statistical Significance ◽  
Maximum Flow ◽  
Prostatic Hyperplasia ◽  
Treatment Rate ◽  
Symptomatic Benign Prostatic Hyperplasia ◽  
Lithium Triborate ◽  
Photoselective Vaporization ◽  
Efficacy Parameters

Objective: We evaluated the safety and efficacy of photoselective vaporization of the prostate (PVP) using GreenLight 120-W lithium triborate (LBO) laser to treat symptomatic small-to-medium sized benign prostatic hyperplasia (BPH).Methods: This prospective non-controlled observational study included symptomatic BPH men ≥50 years with international prostate symptom score (IPSS) ≥14, prostate volume (PV) ≤80 cc and maximum flow rate (Q-max) ≤15 mL/s. PVP was performed using the GreenLight 120-W LBO laser machine. Patients were assessed at baseline and postoperatively at discharge, 2 weeks, and 3, 6 and 12 months. We measured changes in IPSS, PV, PSA, Q-max, post-void residual (PVR), hemoglobin (Hb), serum sodium (Na+) and reported complications. Statistical significance was p < 0.05.Results: The study included 103 men with mean age of 67 (±standarddeviation) ±9.7 years. Thirty patients were on indwelling urethral catheters for refractory urinary retention and 12 on ongoing anticoagulants. The mean baseline IPSS, PV, PSA, Q-max and PVR parameters significantly improved at follow-up (p < 0.001; each). Mean measurements at baseline versus at six months were: IPSS 25.6 ± 4.2 vs. 7.4±2.3; PV 44.6 ± 9.2 vs. 21.6 ± 6.3 cc (51.6% reduction); Q-max 5.8 ± 3.4 vs. 20.4 ± 4.8 mL/s; PVR 110 ± 40 vs. 35 ± 9 cc. Mean baseline Hb and serum Na+ declined nonsignificantly (p > 0.05) at discharge and at 2 weeks. No patient needed a blood transfusion. Secondary procedures were needed in 2 patients for urethral and bladder neck strictures. The re-treatment rate for residual adenoma was 0.97%.Conclusion: PVP using the GreenLight 120-W LBO laser to treat small-to-medium sized symptomatic BPH demonstrated significant improvements in efficacy parameters and high safety profile within 12 months of follow-up. The procedure entails good hemostasis with minimal blood loss even in patients receiving ongoing anticoagulants.

Sign in / Sign up

Export Citation Format

Share Document